Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1830 participants.
Also called NCT03125772
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,830 participants
- Sponsor
- Registry
-
NCT03125772 -
CTRI/2011/06/001830
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT03125772. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2015-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics
- Acronym
- Tuxedo
- Condition
- Type 2 Diabetes
- Condition
- Coronary Heart Disease
- Intervention (Device)
- TAXUS Element™ Paclitaxel-Eluting Stent System
- Intervention (Device)
- Xience PRIME Everolimus-Eluting Stent System
- Lead sponsor
- Fortis Escorts Heart Institute
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Max Neeman Medical International Ltd.
Record details
- Record id
cardio:ct-nct03125772- Content hash
1d3b9f2867be773715b69fef38c0ffd22c14de02c7fdf78cc645b7421442c0b2